← All trials
NCT03308396
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 19, 2017
- Primary completion
- Dec 1, 2019
- Completion date
- Dec 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 58
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Big Ten Cancer Research ConsortiumLead sponsor
- AstraZenecaCollaborator
- University of MichiganOverall official - principal investigator
- Big Ten Cancer Research ConsortiumCollaborator
- Big Ten Cancer Research ConsortiumSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.